Illumina

Illumina is a leading provider of genomics solutions, specializing in next-generation sequencing (NGS) and microarray technology. The company offers a comprehensive range of products, including sequencing platforms, reagents, and bioinformatics software, designed to enable high-quality genomic analysis for research and clinical applications. Illumina's innovations empower researchers and clinicians worldwide to accelerate discoveries and translate genomic insights into actionable health improvements. Their mission is to improve human health by unlocking the power of the genome, focusing on areas like cancer research, reproductive health, and genetic diseases. With a commitment to innovation and collaboration, Illumina supports a wide array of genomic studies and applications through advanced sequencing technologies.